News
KWES morning anchor Victor Lopez let viewers know that he is fighting stage 4 colon cancer. "I was diagnosed with ...
4h
Live Science on MSNCancer: Facts about the diseases that cause out-of-control cell growthThe risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...
Researchers at Mayo Clinic's Center for Individualized Medicine have discovered a rare genetic variant that can directly ...
8h
News-Medical.Net on MSNDT-109 shows promise in treating atherosclerosis and liver diseaseA drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.
9hon MSN
Liver cancer is surging in South India and now, even kids are at risk. Could your rice be making you sick? Experts reveal ...
Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
The FDA has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for unresectable or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results